Parallax Volatility Advisers’s Novartis NVS Stock Holding History

Parallax Volatility Advisers’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	+1,602	New	+$240K	﹤0.01%	1210
2025 Q1	–	Sell	-803	Closed	-$78.1K	–	1973
2024 Q4	$78.1K	Buy	+803	New	+$85.6K	﹤0.01%	1752
2022 Q1	–	Sell	-138,997	Closed	-$12.2M	–	3230
2021 Q4	$12.2M	Buy	138,997 +135,356	+3,718%	+$11.2M	0.01%	815
2021 Q3	$298K	Buy	+3,641	New	+$328K	﹤0.01%	2417
2021 Q1	–	Sell	-57	Closed	-$5K	–	3530
2020 Q4	$5K	Sell	57 -766	-93%	-$66.9K	﹤0.01%	3227
2020 Q3	$72K	Buy	823 +807	+5,044%	+$69.9K	﹤0.01%	2784
2020 Q2	$1K	Buy	+16	New	+$1.38K	﹤0.01%	2665
2020 Q1	–	Sell	-2,438	Closed	-$218K	–	2642
2019 Q4	$231K	Sell	2,438 -5,554	-69%	-$498K	﹤0.01%	1977
2019 Q3	$695K	Sell	7,992 -167,931	-95%	-$15.1M	﹤0.01%	1519
2019 Q2	$16.1M	Sell	175,923 -33,567	-16%	-$2.84M	0.02%	415
2019 Q1	$18M	Buy	209,490 +208,854	+32,839%	+$16.8M	0.02%	337
2018 Q4	$49K	Sell	636 -85,244	-99%	-$6.64M	﹤0.01%	2132
2018 Q3	$6.63M	Buy	+85,880	New	+$6.35M	0.01%	613

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parallax Volatility Advisers's NVS Position: Q2 2026 in Review

Parallax Volatility Advisers opened a new position in Novartis (NVS) in Q2 2026: 1,602 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1210 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in NVS as recently as Q4 2024.

Parallax Volatility Advisers first reported a position in NVS in Q3 2018 and has held it in 13 quarters since. The position peaked at $18M in Q1 2019. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Parallax Volatility Advisers held 1,602 shares of Novartis worth $251K as of Q2 2026.
Novartis was a new Parallax Volatility Advisers position in Q2 2026.
Novartis made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q2 2026, its #1210 holding.
Parallax Volatility Advisers first reported a position in Novartis in Q3 2018 and has held it in 13 quarters since.
Parallax Volatility Advisers's Novartis position peaked at $18M in Q1 2019.
1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.